Table 2.
Prescription of Medications Often Used to Treat CKD-aPa, by Self-Reported Extent Bothered by Itchy Skin
| Overall | Self-Reported Extent Bothered by Itchy Skin |
|||||
|---|---|---|---|---|---|---|
| 1: Not At All Bothered | 2: Somewhat Bothered | 3: Moderately Bothered | 4: Very Much Bothered | 5: Extremely Bothered | ||
| Patients, N | 4,410 | 2,167 | 1,198 | 595 | 329 | 121 |
| Antihistamine, n (%) | 228 (6%) | 93 (5%) | 45 (4%) | 51 (9%) | 24 (8%) | 15 (14%) |
| Gabapentinoids, n (%) | 243 (6%) | 94 (5%) | 68 (6%) | 38 (7%) | 26 (8%) | 17 (16%) |
| Gabapentin, n (%) | 158 (4%) | 56 (3%) | 50 (5%) | 25 (5%) | 16 (5%) | 11 (10%) |
| Pregabalin, n (%) | 88 (2%) | 39 (2%) | 20 (2%) | 13 (2%) | 10 (3%) | 6 (6%) |
| Topical corticosteroids, n (%) | 136 (3%) | 59 (3%) | 37 (3%) | 21 (4%) | 11 (4%) | 8 (8%) |
| Sedating antihistamines, n (%) | 69 (2%) | 24 (1%) | 14 (1%) | 12 (2%) | 13 (4%) | 6 (6%) |
| Any prescription of above, n (%) | 614 (15%) | 247 (12%) | 151 (14%) | 109 (20%) | 67 (22%) | 40 (38%) |
Note: Prescription (yes or no) was captured, but not the indication or condition for the medication. N (%) patients shown.
a
Within 185 days from the first patient questionnaire with the completion of the pruritus survey question.